220 related articles for article (PubMed ID: 33606788)
21. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
[TBL] [Abstract][Full Text] [Related]
22. A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony-stimulating factor.
Feyen J; Ernst MPT; van der Velden VHJ; Valk PJM; Broeders L; Touw IP; Raaijmakers MHGP
Pediatr Blood Cancer; 2023 Apr; 70(4):e30039. PubMed ID: 36316822
[TBL] [Abstract][Full Text] [Related]
23. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
24. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
Wu B; Tao L; Yang D; Li W; Xu H; He Q
Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
[TBL] [Abstract][Full Text] [Related]
25. Integrated Profiling Identifies
Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
Front Immunol; 2021; 12():722807. PubMed ID: 34646265
[TBL] [Abstract][Full Text] [Related]
26. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
27. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
[TBL] [Abstract][Full Text] [Related]
28. Expression of NOX Family Genes and Their Clinical Significance in Colorectal Cancer.
Cho SY; Kim JS; Eun HS; Kang SH; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY; Moon HS
Dig Dis Sci; 2018 Sep; 63(9):2332-2340. PubMed ID: 29781053
[TBL] [Abstract][Full Text] [Related]
29. Tumor immune microenvironment in cancer patients with leukocytosis.
Kim KH; Sim NS; Chang JS; Kim YB
Cancer Immunol Immunother; 2020 Jul; 69(7):1265-1277. PubMed ID: 32170377
[TBL] [Abstract][Full Text] [Related]
30. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
31. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
Zhang J; Liu W; Feng S; Zhong B
World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
[TBL] [Abstract][Full Text] [Related]
32. RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
Mini E; Lapucci A; Perrone G; D'Aurizio R; Napoli C; Brugia M; Landini I; Tassi R; Picariello L; Simi L; Mancini I; Messerini L; Magi A; Pinzani P; Mazzei T; Tonelli F; Nobili S
Int J Cancer; 2019 Nov; 145(9):2580-2593. PubMed ID: 30973654
[TBL] [Abstract][Full Text] [Related]
33. Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer.
Yang R; Cai TT; Wu XJ; Liu YN; He J; Zhang XS; Ma G; Li J
Immunology; 2018 Oct; 155(2):263-272. PubMed ID: 29770434
[TBL] [Abstract][Full Text] [Related]
34. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
Lu C; Liao W; Huang Y; Huang Y; Luo Y
BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
[TBL] [Abstract][Full Text] [Related]
36. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
Chen E; Li Q; Wang H; Yang F; Min L; Yang J
Biomed Pharmacother; 2018 Oct; 106():1370-1377. PubMed ID: 30119209
[TBL] [Abstract][Full Text] [Related]
37. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
[TBL] [Abstract][Full Text] [Related]
38. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
39. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
Yu J; Yang K; Zheng J; Sun X; Zhao W
Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
